Technavio, a leading provider of market research reports, has released its latest study on Effervescent Tablet Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. The young demographic segment has shown a trend of avoiding nutritious food, leading to an increased prevalence of nutrient deficiencies. To address this issue, the market for effervescent tablets, a type of nutraceutical product, has gained significant traction. These tablets, available in various formats, shapes, and flavors, offer a fun and convenient solution for meeting daily nutritional requirements. Vendors like Strava Healthcare Pvt. Ltd. cater to this demand by providing effervescent vitamin products in appealing shapes and various flavors. Moreover, there is a growing awareness among parents regarding the importance of providing their children with high-quality vitamin supplements, further fueling the demand for effervescent tablets.
The global effervescent tablet market size is estimated to grow by USD 4.80 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.36% during the forecast period. Increasing adoption of effervescent tablets among aging population is driving market growth, with a trend towards availability of effervescent supplements for youth and children. However, high sodium content in effervescent tablets poses a challenge. Some of the key industry leaders include Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories.
Know what is trending in the market - Access a free sample report!
A sedentary lifestyle exacerbates the risk of various illnesses, including chronic pain and respiratory diseases. With over 39 million Americans affected by migraines and approximately 15.7 million with COPD, the need for efficient and accessible treatment options, such as effervescent pills, is growing.
Effervescent tablets, while effective for treating conditions like migraines and hyperacidity, face market limitations due to their high sodium content, which can lead to complications in patients with chronic conditions such as diabetes and asthma. The sodium may cause blood pressure issues in diabetics and worsen asthma symptoms.
The use of effervescent tablets alongside other medications, such as opioid analgesics, antihistamines, and muscle relaxants, can lead to side effects like dizziness, nausea, and breathing difficulties, potentially reducing patient adherence and impacting market growth.
According to Technavio, the global effervescent tablet market is a segment of the expansive global pharmaceuticals industry, encompassing entities involved in R&D and manufacturing of various pharmaceutical products, including generic and non-generic drugs, veterinary medicines, and biotechnology solutions. The size of the global healthcare industry, which includes the pharmaceuticals sector, is determined by Technavio based on the consolidated revenue generated from the sales of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The growth of the global pharmaceuticals market is anticipated to be driven by several key factors, including the increasing elderly population, whose numbers are projected to rise significantly.
The Effervescent Tablet Market is experiencing significant growth, fueled by the Increasing adoption of effervescent tablets among aging population. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
For insights on company offerings- Request a sample report!
The effervescent tablet market in North America is experiencing significant growth due to the increasing consumer preference for health-conscious products, including dietary supplements, probiotics, vitamins, and minerals. This trend is driven by the rising awareness of maintaining a healthy lifestyle and preventing lifestyle diseases. Factors such as the increasing disposable income of consumers, continuous product innovations, and the expanding retail space in the region are further boosting market growth. However, regulatory challenges particularly through online sales channels, pose a significant hindrance to market expansion. Despite this, the market is expected to continue its upward trajectory, fueled by the relentless pursuit of wellness and the unyielding demand for convenient and effective health solutions.
The effervescent tablet market caters to various demographic groups, particularly those dealing with health issues related to vitamins and minerals deficiencies. Producers of effervescent tablets have identified significant market opportunities, as these tablets offer advantages over conventional solid dosage forms like capsules and tablets. The effervescent reaction, which involves the release of carbon dioxide upon contact with water, provides faster dissolution and improved bioavailability. However, the manufacturing process of effervescent tablets involves additional processing steps, such as tablet disintegration, mixing, granulation, and tablet compression. These steps increase production costs and require specialized equipment, raw ingredients, personnel, and regulatory compliance. According to a study published in the 'Pharmaceuticals' journal, the high production costs and additional packaging needs are market restraints for the effervescent tablet industry. Nevertheless, the growing trend towards precise ingredient control and the overall health benefits associated with vitamins and minerals make effervescent tablets an attractive option for consumers. Despite the challenges, the market for effervescent tablets, including those for dietary supplements, is expected to grow due to their unique benefits and the increasing demand for convenient and effective health solutions.
Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
